IP-001

DRUG2 trials

Sponsors

Swiss Cancer Institute, M.R. Meijerink

Conditions

Advanced Solid TumorsColorectal CancerLiver MetastasesLiver Metastasis Colon Cancer

Phase 1

Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors.

CompletedNCT03993678

Swiss Cancer InstituteAdvanced Solid Tumors

Start: 2020-10-12End: 2025-07-19Updated: 2025-12-30

Dose Finding, Efficacy and Immunological Response of IP-001 Following MWA or IRE for CRLM

RecruitingNCT06630624

M.R. MeijerinkColorectal Cancer, Liver Metastases, Liver Metastasis Colon Cancer

Start: 2024-07-10End: 2031-08-01Target: 120Updated: 2025-07-03

Related Papers

Intratumoral injection of IP-001 following thermal ablation in patients with advanced solid tumors: A multicenter phase Ib/IIa trial with expansion cohorts in melanoma and soft tissue sarcoma patients (SAKK 66/17).

Journal of Clinical Oncology2026-05-27